• home
  • ICKSH
  • Scientific Program

Scientific Program

  • Thursday, March 30
  • Friday, March 31
  • Saturday, April 1

Thursday, March 30

[CS01] Collaborative Session 01: Innovative diagnostic technologies

Date & Time March 30 (Thursday), 9:00-10:15 Room 1
Chairs Jin-Yeong Han (Dong-A University College of Medicine, Korea)
In-Suk Kim (Pusan National University School of Medicine, Korea)
Presentations
  • Accelerate breakthroughs in hematology with single cell sequencing
    Geoffrey McDermott (10x Genomics, Inc., USA)
  • AI technology in the field of blood disease
    Tabe Yoko (Juntendo University, Japan)
  • Discover the unique power of using droplet digital PCR (ddPCR) for hematology-oncology applications
    Gina Sun (Bio-Rad Laboratories, USA))
  • Holotomography and artificial intelligence: label-free 3D imaging, classification, and inference
    YongKeun Park (Tomocube Inc., Korea)

[SS01] Scientific Session 01: Challenging issues in childhood blood disorders

Date & Time March 30 (Thursday), 9:00-10:15 Room 2
Chairs Hoon Kook (Chonnam National University Medical School, Korea)
Nack-Gyun Chung (The Catholic University of Korea, Korea)
Presentations
  • How to diagnosis and treat neutropenia in childhood
    Kelly Walkovich (University of Michigan, USA)
  • Updates in the treatment of pediatric relapsed/refractory acute myeloid leukemia
    Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea)
  • Use of chimeric antigen receptor (CAR) expressing T cells for acute lymphoblastic leukemia (ALL)
    Micheal Verneris (Children’s Hospital Colorado, USA)

[SS02] Scientific Session 02: How far has cell therapy developed in Hodgkin lymphoma?

Date & Time March 30 (Thursday), 9:00-10:15 Room 3
Chairs Hyeon-Seok Eom (National Cancer Center, Korea)
Sung-yong Oh (Dong-A University College of Medicine, Korea)
Presentations
  • Pathogenesis of hodgkin lymphoma
    Ralf Küppers (University of Duisburg-Essen, Germany)
  • Emerging cellular therapy in HL
    Natalie S Grover (The University of North Carolina at Chapel Hill, USA)
  • Novel treatment of relapsed/refractory hodgkin lymphoma
    Hyeon-Seok Eom (National Cancer Center, Korea)

[ES01] Education Session 01: Different treatment goals for overcoming resistance or functional cure in CML

Date & Time March 30 (Thursday), 9:00-10:15 Room 4
Chairs Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)
Hawk Kim (Gachon University College of Medicine, Korea)
Presentations
  • Asciminib: the first-in-class allosteric inhibitor of BCR/ABL1 kinase
    Eun-Ji Choi (University of Ulsan College of Medicine, Korea)
  • Treatment after failure of frontline therapy of CML-CP including allo-HSCT
    Jieun Uhm (Hanyang University College of Medicine, Korea)
  • Update on treatment free remission
    Jae Joon Han (Kyung Hee University College of Medicine, Korea)

[PL01] Plenary Lecture 01

Date & Time March 30 (Thursday), 10:30-11:15 Room 1
Chair Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Presentation
  • Regulation of iron metabolism
    Martina U. Muckenthaler (University of Heidelberg, Germany)

[PS01] Presidential Symposium

Date & Time March 30 (Thursday), 11:15-12:00 Room 1
Chairs Seongsoo Jang (University of Ulsan College of Medicine, Korea)
Presentation
  • What can Nano do for Medicine?
    Taeghwan Hyeon (Seoul National University, Korea)

[SY01] Satellite Symposium 01 (Sponsored by Novartis)

Date & Time March 30 (Thursday), 12:15-13:05 Room 1
Chair Dong-Wook Kim (Eulji University School of Medicine, Korea)
Presentation
  • ASCIMINIB, new paradigm treatment option in CML for patients who were previously treated with 2 or more TKIs
    Andreas Hocchaus (Jena University Hospital, Germany)

[SY02] Satellite Symposium 02 (Sponsored by Roche)

Date & Time March 30 (Thursday), 12:15-13:05 Room 2
Chair Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation
  • Unmet need in 1L DLBCL and POLARIX trial
    Georg Lenz (University Hospital in Münster, Germany)

[SY03] Satellite Symposium 03 (Sponsored by BMS-Celgene)

Date & Time March 30 (Thursday), 12:15-13:05 Room 3
Chair Ho Sup Lee (Kosin University College of Medicine, Korea)
Presentation
  • Maintenance treatment post autotransplant for multiple myeloma
    Kevin Song (Vancouver General Hospital, Canada)

[JS01] Asian Hematology Session I (JSM & KMMWP) - Multiple Myeloma

Date & Time March 30 (Thursday), 15:05-16:20 Room 1
Chairs Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
Chiaki Nakaseko (International University of Health and Welfare School of Medicine, Japan)
Presentations
  • POEMS syndrome: advances in molecular pathophysiology and treatment
    Chiaki Nakaseko (International University of Health and Welfare School of Medicine, Japan)
  • Updates on POEMS syndrome in Korea
    Jin Seok Kim (Yonsei University College of Medicine, Korea)
  • Therapeutic approach of Waldenström's macroglobulinemia in Japan
    Hiroshi Handa (Gunma University, Japan)
  • Clinical researches on Waldenström's macroglobulinemia in Korea
    Hosup Lee (Kosin University College of Medicine, Korea)

[SS03] Scientific Session 03: Where we are, in the era of new agents for aplastic anemia?

Date & Time March 30 (Thursday), 15:05-16:20 Room 2
Chairs Jae Wook Lee (The Catholic University of Korea, Korea)
Ho Joon Im (University of Ulsan College of Medicine, Korea)
Presentations
  • Aplastic anemia: Current management considerations
    Emma M. Groarke (National Institutes of Health, USA)
  • Clinical and molecular factors of clonal evolution in aplastic anemia
    Jaroslaw P. Maciejewski (Cleveland Clinic, USA)
  • Non-transplant therapy for pediatric aplastic anemia
    Jae Wook Lee (The Catholic University of Korea, Korea)

[SS04] Scientific Session 04: How can we approach thrombocytopenia?

Date & Time March 30 (Thursday), 15:05-16:20 Room 3
Chairs Soo-Mee Bang (Seoul National University College of Medicine, Korea)
Hyun Kyung Kim (Seoul National University College of Medicine, Korea)
Presentations
  • Diagnosis and treatment of TA-TMA; Current challenge and future strategies
    Sandro Rossetti (Hospital Alexion Pharmaceuticals, Inc., USA)
  • Genetics of inherited thrombocytopenia
    Kathleen Freson (University of Leuven, Belgium)
  • Advances on pathogenesis and diagnosis of TTP
    Hyun Kyung Kim (Seoul National University College of Medicine, Korea)

[ES02] Education Session 02: How I treat rare lymphomas?

Date & Time March 30 (Thursday), 15:05-16:20 Room 4
Chairs Hyo Jung Kim (Hallym University College of Medicine, Korea)
Dok Hyun Yoon (Asan Medical Center, University of Ulsan College of Medicine, Korea)
Presentations
  • Intravascular B-cell lymphoma
    Youngwoo Jeon (The Catholic University of Korea, Korea)
  • T-large granular lymphocytic leukemia
    Jae-Cheol Jo (University of Ulsan College of Medicine, Korea)
  • Lymphomatoid granulomatosis
    Jeong-Ok Lee (Seoul National University Bundang Hospital, Korea)

[CS02] Collaborative Session 02: Innovative therapeutic technologies

Date & Time March 30 (Thursday), 16:35-17:50 Room 1
Chairs Keon Hee Yoo (Sungkyunkwan University School of Medicine, Samsung Medical Center, Korea)
Yong Park (Korea University school of medicine, Korea)
Presentations
  • A Phase 1a Study of BR101801, PI3Kγδ and DNA PK Triple Inhibitor, in Adult Patients with Advanced Hematologic Malignancies
    Bong-Seog Kim (Boryung Co. Ltd., Korea)
  • The gut microbiome as a novel predictive biomarker and therapeutic target in lymphoma patients
    Woorim Kang (CJ Bioscience Inc., Korea)
  • Bispecific antibody : ABL Bio
    Jonghwa Won (ABL Bio Inc., Korea)
  • TKI development in CML
    Sung-Min Ahn (ImmunoForge Inc., Korea)

[SS05] Scientific Session 05: Artificial intelligence application in hematology

Date & Time March 30 (Thursday), 16:35-17:50 Room 2
Chairs Mina Hur (Konkuk University School of Medicine, Korea)
Myung-Hyun Nam (Korea University school of medicine, Korea)
Presentations
  • Artificial intelligence in hematology: basic concepts
    Roni Shouval (Memorial Sloan Kettering Cancer Center, USA)
  • How ML deepens our understanding of hematologic malignancies?
    Valeria Visconte (Cleveland Clinic, USA)
  • Pitfalls of AI for medical application
    Jongmun Choi (Green Cross Genome, Korea)

[SS06] Defining and improving survival of high-risk multiple myeloma

Date & Time March 30 (Thursday), 16:35-17:50 Room 3
Chairs Chang-Ki Min (The Catholic University of Korea, Korea)
Jin Seok Kim (Yonsei University College of Medicine, Korea)
Presentations
  • Identification of high-risk multiple myeloma
    Niels van de Donk (Amsterdam University Medical Center, The Netherlands)
  • Updated diagnosis and treatment of plasma cell leukemia
    Sung-Hoon Jung (Chonnam National University Hwasun Hospital , Korea)
  • Safety and efficacy of locally produced novel BCMA CART cells for relapsed/refractory multiple myeloma and al amyloidosis
    Moshe Gatt (The Hebrew University of Jerusalem, Israel)

[ES03] Education Session 03: Rare hematologic malignancies with cutaneous manifestation

Date & Time March 30 (Thursday), 16:35-17:50 Room 4
Chairs Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea)
Ahn Jae-Sook (Chonnam National University Hwasun Hospital, Korea)
Presentations
  • Sezary syndrome and mycosis fungoides
    Hyewon Lee (National Cancer Center, Korea)
  • Systemic mastocytosis
    Hyun Jung Lee (Kyung Hee University College of Medicine, Korea)
  • Plasmacytoid dendritic cell neoplasm
    Yoo Jin Lee (University of Ulsan College of Medicine, Korea)

Friday, March 31

[JS02] ASH-KSH Joint Symposium - T Cell Lymphoma

Date & Time March 31 (Friday), 9:00-10:15 Room 1
Chairs Seong soo Jang (University of Ulsan College of Medicine, Korea)
Robert Brodsky (John Hopkins University, USA)
Presentations
  • NK cells: next generation cell therapies for cancer
    Katy Rezvani (The University of Texas MD Anderson Cancer Center, USA)
  • Treatment of extranodal NK/T-cell lymphoma: Korean Lymphoma Working Party experience
    Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
  • CART for the treatment of T cell malignancies
    John DiPersio (Washington University School of Medicine, USA)
  • Treatment of peripheral T-cell lymphoma: Korean Lymphoma Working Party experience
    Deok-Hwan Yang (Chonnam National University Medical School, Korea)

[SS07] Scientific Session 07: What is the direction of the new CAR-T therapy?

Date & Time March 31 (Friday), 9:00-10:15 Room 2
Chairs Seok-Goo Cho (The Catholic University of Korea, Korea)
Je-Jung Lee (Chonnam National University Medical School, Korea)
Presentations
  • Engineering next-generation T cells for cancer immunotherapy
    Yvonne Chen (University of California, USA)
  • Development of CAR-T therapy for acute lymphoblastic leukemia
    Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
  • Updates on the latest developments in CAR-T therapies
    Hiroshi Fujiwara (Mie University, Japan)

[SS08] Scientific Session 08: Comprehensive approaches to understand hemophilia

Date & Time March 31 (Friday), 9:00-10:15 Room 3
Chairs Eun Jin Choi (Daegu Catholic University Hospital, Korea)
Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
Presentations
  • Genotyping of hemophilia, why we need it and how we do?
    Jill Johnsen (University of Washington, USA)
  • Value of national cohort registry data of hemophilia
    Jung Woo Han (Yonsei University College of Medicine, Korea)
  • Essentials of laboratory issues in Emicizumab
    Sang Hyuk Park (Ulsan University Hospital, Korea)

[ES04] Education Session 04: Back to the basic: transfusion support

Date & Time March 31 (Friday), 9:00-10:15 Room 4
Chairs Jong Ho Won (Soonchunhyang University College of Medicine, Korea)
Ji Hyang LIM (The Catholic University of Korea, Korea)
Presentations
  • Transfusion support for HSCT
    Dong Wook Jekarl (The Catholic University of Korea, Korea)
  • Evidence based transfusion threshold
    Dae-Hyun Ko (University of Ulsan College of Medicine, Korea)
  • Current status of manufactured blood cells
    Eun Jung Baek (Hanyang University College of Medicine, Korea)

[PL02] Plenary Lecture 02

Date & Time March 31 (Friday), 10:30-11:15 Room 1
Chair Chul-Ju Yoo (Yonsei University College of Medicine, Korea)
Presentation
  • The role of the intestinal microbiome in cancer immunotherapy
    Marcel van den Brink (Memorial Sloan Kettering Cancer Center, USA)

[SY04] Satellite Symposium 04 (Sponsored by Kyowa Kirin)

Date & Time March 31 (Friday), 12:15-13:05 Room 1
Chairs Jong Wook Lee (Seoul St. Mary's Hospital, The Catholic University of Korea, Korea)
Presentation
  • Recent advances in the pathogenesis and treatment of aplastic anemia
    Kohei Hosokawa (Kanazawa University, Japan)

[SY05] Satellite Symposium 05 (Sponsored by Handok)

Date & Time March 31 (Friday), 12:15-13:05 Room 2
Chair Je-Hwan Lee (University of Ulsan College of Medicine, Korea)
Presentation
  • Value of intensive therapy in high-risk AML
    Martin Bornhaeuser (University Hospital Carl Gustav Carus Dresden, Germany)

[SY06] Satellite Symposium 06 (Sponsored by Janssen)

Date & Time March 31 (Friday), 12:15-13:05 Room 3
Chair Won Seog Kim (Sungkyunkwan University School of Medicine, Korea)
Presentation
  • When and whom to start treatment of CLL patients and how to optimally manage CLL patients with Imbruvica
    Paolo Ghia (IRCCS Ospedale San Raffaele, Italy)

[JS03] EHA-KSH Joint Symposium - Myelodysplastic Syndrome

Date & Time March 31 (Friday), 15:05-16:20 Room 1
Chairs June-Won Cheong (Yonsei University College of Medicine, Korea)
Lionel Adès (Hospital Saint Louis and Paris University, France)
Presentations
  • Novel approaches in MDS
    Uwe Platzbecker (Leipzig University Hospital, Germany)
  • Treatment of MDS: Korean AML/MDS working party experience
    June-Won Cheong (Yonsei University College of Medicine, Korea)
  • Standard management of MDS
    Lionel Adès (Hospital Saint Louis and Paris University, France)
  • Genetic alterations in myelodysplastic neoplasms
    Yoo-Jin Kim (The Catholic University of Korea, Korea)

[SS09] Scientific Session 09: Which immune therapy is our future weapon against AML?

Date & Time March 31 (Friday), 15:05-16:20 Room 2
Chairs Hyeoung-Joon Kim (Chonnam National University Medical School, Korea)
Hee-Je Kim (The Catholic University of Korea, Korea)
Presentations
  • Immune checkpoint inhibition for AML ; CD47 blockade and beyond
    Naval Daver (MD Anderson Cancer Center, USA)
  • Determining the barriers to successful CAR T cell therapy for AML
    Miriam Y Kim (University of Washington, USA)
  • Adoptive T cell transfer of three universal tumor associated antigens-specific T cells for the treatment of AML
    Byung Sik Cho (The Catholic University of Korea, Korea)

[SS10] Scientific Session 10: Next-generation molecular genomic and cytogenomic technology in hematology

Date & Time March 31 (Friday), 15:05-16:20 Room 3
Chairs Myungshin Kim (The Catholic University of Korea, Korea)
Yoon Hwan Chang (Seoul National University Hospital, Korea)
Presentations
  • A transcriptomic approach to clinical diagnosis, prognosis and therapy selection in AML
    Aly Karsan (University of British Columbia, Canada)
  • Whole genome sequencing of fluorescence in situ hybridized cells in hematologic malignancies using SLACS
    Sunghoon Kwon (Seoul National University, Korea)
  • Next generation cytogenetics – optical mapping for comprehensive structural variant detection in hematological malignancies and beyond
    Alexander Hoischen ((Radboud University Medical Center, The Netherlands))

[ES05] Education Session 05: Practical issue in CAR-T

Date & Time March 31 (Friday), 15:05-16:20 Room 4
Chairs Jae-Yong Kwak (Jeonbuk National University Hospital, Korea)
Hyoung Jin Kang (Seoul National University College of Medicine, Korea)
Presentations
  • Setting up the facility for CAR T cell therapy
    Ja Min Byun (Seoul National University College of Medicine, Korea)
  • Technical aspect of manufacturing CAR T cell product
    Jong-Seo Lee (AbClon Inc., Korea)
  • Managing adverse events of CAR T cell therapy
    Jae Won Yoo (The Catholic University of Korea, Korea)

[JS04] International Collaborative Session - Aplastic Anemia

Date & Time March 31 (Friday), 16:35-17:50 Room 1
Chairs Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
Lalita Norasetthada (Chiang Mai University, Thailand)
Presentations
  • Overview of AA diagnosis and treatment in NIHBT, VietNam
    Nguyen Thi Thao (National Institute of Hematology and Blood Transfusion, Vietnam)
  • The incidence and real-world outcome of aplastic anemia in Thailand
    Lalita Norasetthada (Chiang Mai University, Thailand)
  • Role of TPO receptor agonists in aplastic anemia treatment
    Jun Ho Jang (Samsung Medical Center, Korea)

[SS11] Scientific Session 11: Liquid biopsy application in hematology

Date & Time March 31 (Friday), 16:35-17:50 Room 2
Chairs Myung Geun Shin (Chonnam National University Medical School, Korea)
Seung-Tae Lee (Yonsei University College of Medicine, Korea)
Presentations
  • Cell-free DNA profiling for monitoring of complications of hematopoietic cell transplantation
    Iwijn De Vlaminck (Cornell University, USA)
  • Microbial cell-free DNA sequencing to predict bloodstream infection in pediatric cancer patients
    Charles Gawad (Stanford University, USA)
  • Clinical applications of circulating tumor DNA analysis in lymphoma
    Seung-Tae Lee (Yonsei University College of Medicine, Korea)

[SS12] Scientific Session 12: Up-to-date diagnostic and treatment strategies of adult ALL patients

Date & Time March 31 (Friday), 16:35-17:50 Room 3
Chairs Ho-Jin Shin (Pusan National University Hospital, Korea)
Seok Lee (The Catholic University of Korea, Korea)
Presentations
  • Are we moving towards a chemo- and transplant-free management of Ph-positive adult ALL?
    Robin Foa (Sapienza University of Rome, Italy)
  • Development of more-effective CAR T-cell therapy for ALL
    Saar I Gill (University of Pennsylvania, USA)
  • Overcoming high-risk features in adult ALL patients
    Jae-Ho Yoon (The Catholic University of Korea, Korea)

Saturday, April 1

[JS05] Asian Hematology Session II - Red Blood Cell Disorder

Date & Time April 1 (Saturday), 9:00-10:15 Room 1
Chairs Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea)
Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
Presentations
  • Overview of thalassaemia and hemoglobinopathies in Bangladesh
    Mahmood A. Chowdhury (Chattogram Maa-O-Shishu Hospital Medical College, Bangladesh)
  • Current situation of thalassemia care in Cambodia
    Chean Sophal (National Pediatric Hospital, Cambodia)
  • Epidemiology and diagnosis of hemolytic anemia in Korea
    Heewon Chueh (Dong-A University College of Medicine, Korea)

[SS13] Scientific Session 13: Current knowledge of human hematopoietic stem cell

Date & Time April 1 (Saturday), 9:00-10:15 Room 2
Chairs Deog-Yeon Jo (Chungnam National University College of Medicine, Korea)
Byung-Soo Kim (Korea University College of Medicine, Korea)
Presentations
  • Single cell HSPC map
    William J. Greenleaf (Stanford University, USA)
  • Humanized mouse and non-human primate: Animal models for hematopoietic stem cell research
    Kyung-Rok Yu (Seoul National University, Korea)
  • What we know about HSC homing?
    Xinxin Huang (Fudan University, China)

[SS14] Scientific Session 14: What's new in chronic lymphocytic leukemia?

Date & Time April 1 (Saturday), 9:00-10:15 Room 3
Chairs Young Rok Do (Keimyung University School of Medicine, Korea)
TBD
Presentations
  • Translating scientific advances in CLL
    Richard Rosenquist (Karolinska Institute, Sweden)
  • Patient selection for time limited versus continued therapy
    Jennifer R. Brown (Dana-Farber Cancer Institute, USA)
  • MRD monitoring in CLL Patients
    Ki-Seong Eom (The Catholic University of Korea, Korea)

[ES06] Education Session 06: Novel therapeutics for myeloproliferative neoplasms

Date & Time April 1 (Saturday), 9:00-10:15 Room 4
Chairs Sung-Yong Kim (Konkuk University School of Medicine, Korea)
Chul Won Choi (Korea University Guro Hospital, Korea)
Presentations
  • Prognostication in MPNs (including mutation abnormalities)
    Junshik Hong (Seoul National University Hospital, Korea)
  • Novel Therapeutics for MF (including cyotpenic myelofibrosis)
    Sung-Eun Lee (The Catholic University of Korea, Korea)
  • Novel Therapeutics for ET/PV
    Seugyun Yoon (Soonchunhyang University Seoul Hospital, Korea)

[PL03] Plenary Lecture 03

Date & Time April 1 (Saturday), 10:30-11:15 Room 1
Chairs Kyung Ha Ryu (Ewha Womans University, Korea)
Presentation
  • Recent advance in the hematopoietic stem cell research
    Toshio Suda (National University of Singapore, Singapore)
Organized by
Supported by

Sponsored by